DePrince Race & Zollo Inc (DRZ) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$88.5M |
| 2 |
PX
Praxair Inc
PX
|
+$71.2M |
| 3 |
Coca-Cola
KO
|
+$67.1M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$51.4M |
| 5 |
Flowers Foods
FLO
|
+$49.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$100M |
| 2 |
URS
URS CORP
URS
|
+$86.4M |
| 3 |
Northern Trust
NTRS
|
+$82M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$78.1M |
| 5 |
Kohl's
KSS
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.45% |
| 2 | Consumer Discretionary | 14.54% |
| 3 | Industrials | 14.15% |
| 4 | Energy | 10.59% |
| 5 | Technology | 7.6% |
Similar funds
DePrince Race & Zollo Inc (DRZ)'s Q3 2014 Portfolio in Review
As of Q3 2014, DePrince Race & Zollo Inc (DRZ) held 336 positions worth $7.4B, down 13% from $8.52B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
DePrince Race & Zollo Inc (DRZ) withdrew a net $592M in Q3 2014, closing 54 positions and reducing 165 holdings. Its most notable exit was Amgen, an estimated $100M position sold in full.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, DePrince Race & Zollo Inc (DRZ) opened a new position in Pfizer worth $88.5M.
- DePrince Race & Zollo Inc (DRZ)'s largest Q3 2014 buy was Pfizer: 3,153,779 shares worth $88.5M.
- DePrince Race & Zollo Inc (DRZ) added most to Emerson Electric in Q3 2014, an estimated $34.5M increase.
- DePrince Race & Zollo Inc (DRZ)'s biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $44.4M.
- DePrince Race & Zollo Inc (DRZ) fully exited Amgen in Q3 2014, selling an estimated $100M.
- DePrince Race & Zollo Inc (DRZ)'s ten largest holdings make up 13% of its $7.4B portfolio in Q3 2014.
- DePrince Race & Zollo Inc (DRZ) opened 39 new positions and closed 54 in Q3 2014.
- DePrince Race & Zollo Inc (DRZ)'s portfolio value fell 13% quarter-over-quarter to $7.4B.
Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2014, filed 30 Oct 2014.